Neurology
Found 7 results
Filters: Keyword is Cognition  [Clear All Filters]
2022
Perumal J, Balabanov R, Su R, Chang R, Balcer LJ, Galetta SL, Avila RL, Rutledge D, Fox RJ.  2022.  Improvements in Cognitive Processing Speed, Disability, and Patient-Reported Outcomes in Patients with Early Relapsing-Remitting Multiple Sclerosis Treated with Natalizumab: Results of a 4-year, Real-World, Open-Label Study.. CNS Drugs. 36(9):977-993.
2019
Doria J, Karceski S, Doria J, Karceski S.  2019.  Exercise: Can this help to improve or preserve cognitive function throughout adulthood? Neurology. 92(9):e1003-e1006.
2018
Isaacson RS, Ganzer CA, Hristov H, Hackett K, Caesar E, Cohen R, Kachko R, Meléndez-Cabrero J, Rahman A, Scheyer O et al..  2018.  The clinical practice of risk reduction for Alzheimer's disease: A precision medicine approach.. Alzheimers Dement. 14(12):1663-1673.
Mosconi L, Walters M, Sterling J, Quinn C, McHugh P, Andrews RE, Matthews DC, Ganzer C, Osorio RS, Isaacson RS et al..  2018.  Lifestyle and vascular risk effects on MRI-based biomarkers of Alzheimer's disease: a cross-sectional study of middle-aged adults from the broader New York City area.. BMJ Open. 8(3):e019362.
2015
Kuceyeski AF, Vargas W, Dayan M, Monohan E, Blackwell C, Raj A, Fujimoto K, Gauthier SA.  2015.  Modeling the relationship among gray matter atrophy, abnormalities in connecting white matter, and cognitive performance in early multiple sclerosis.. AJNR Am J Neuroradiol. 36(4):702-9.
Berti V, Murray J, Davies M, Spector N, Tsui WH, Li Y, Williams S, Pirraglia E, Vallabhajosula S, McHugh P et al..  2015.  Nutrient patterns and brain biomarkers of Alzheimer's disease in cognitively normal individuals.. J Nutr Health Aging. 19(4):413-23.
1976
Share JB.  1976.  Review of drug treatment for Down's syndrome persons.. Am J Ment Defic. 80(4):388-93.